Study of new drugs for obesity with type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests two new medicines, alone or together, to see if they help with weight loss and blood sugar control in adults who have type 2 diabetes and are overweight or have obesity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes
- Your recent blood sugar test (HbA1c) is between 7.5% and 10.5%
- You have been on a stable treatment plan for diabetes for at least 3 months (like diet and exercise, metformin, or an SGLT2 inhibitor)
- Your weight has been stable (not changed more than 5%) for the last 3 months
- You have a body mass index (BMI) of 27 or higher
- You have not had certain heart problems, such as a heart attack or stroke, in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two new injectable drugs (macupatide and eloralintide) alone or together to help adults with obesity or excess weight lose weight. The goal is to see if these medications are safe and effective for weight management.
This study tests an investigational drug called macupatide to see if it can help people with overweight or obesity lose weight. It is for Japanese adults who do not have type 2 diabetes and have had a stable weight for the past 3 months.
This study tests a new medicine called eloralintide for people with type 2 diabetes who are overweight or have obesity. It aims to see if the drug can help with weight loss and blood sugar control.
This study tests an experimental medicine (eloralintide) to see if it can help people with overweight or obesity lose weight without having diabetes. The medicine works by affecting hormones that help control appetite and body weight.
This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.
This trial tests an experimental drug (Eloralintide) to see if it can help with weight management. It is for people who have a body mass index (BMI) between 25 and 45 and stable weight.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.